Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer
Titel:
Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer
Auteur:
Frank, Katrin J. Mulero-Sánchez, Antonio Berninger, Alexandra Ruiz-Cañas, Laura Bosma, Astrid Görgülü, Kıvanç Wu, Nan Diakopoulos, Kalliope N. Kaya-Aksoy, Ezgi Ruess, Dietrich A. Kabacaoğlu, Derya Schmidt, Fränze Kohlmann, Larissa van Tellingen, Olaf Thijssen, Bram van de Ven, Marieke Proost, Natalie Kossatz, Susanne Weber, Wolfgang A. Sainz Jr., Bruno Bernards, Rene Algül, Hana Lesina, Marina Mainardi, Sara